Back to News
Market Impact: 0.28

Jim Cramer Calls GameStop a Buy: 'They're Having Some Success'

Source: benzinga.com

Analyst InsightsInvestor Sentiment & PositioningCorporate EarningsInsider TransactionsArtificial IntelligenceTechnology & Innovation
Jim Cramer Calls GameStop a Buy: 'They're Having Some Success'

Jim Cramer issued buy recommendations for BlackBerry, Casey's General Stores, GameStop and Credo Technology, with all four shares rising 3.1%-4.2% in the latest session. Casey's posted Q1 EPS of $7.37 versus $6.72 consensus and revenue of $5.678B versus $5.568B expected, while GameStop CEO Ryan Cohen bought 1.0 million shares for $20.38M. BlackBerry announced a QNX partnership with Sift, and Credo launched 224G ZeroFlap optical transceivers for AI networking.

Analysis

The actionable signal is uneven: CASY has a durable earnings-revision pathway if same-store fuel gallons, prepared-food margin and integration synergies continue to outperform, whereas a television endorsement should not materially alter its valuation. At roughly $600/share, the key debate is whether the company can sustain mid-teens EBITDA growth without further multiple expansion; upside over the next 1-3 months requires consensus FY estimates to move higher, not simply a sentiment rebound. A miss in inside-sales margin or dilution from acquisition integration would quickly expose the premium consumer-staples valuation.

CRDO is the higher-beta fundamental setup. The relevant question is whether 224G optical products convert into hyperscaler design wins and revenue, rather than whether a product launch changes near-term earnings; qualification cycles can run 2-4 quarters, while AI-networking expectations are already embedded in the broader optical-connectivity complex. If management confirms material FY2027 revenue contribution or expands gross-margin guidance, CRDO can re-rate with ANET and COHR; absent order visibility, it remains vulnerable to a sharp multiple reset on any digestion commentary.

BB and GME are primarily flow/sentiment trades, not comparable fundamental opportunities. BB's embedded-software optionality needs disclosed contract economics, backlog conversion, or positive segment profitability to overcome its history of monetization disappointment. Cohen's purchase increases GME's meme-stock reflexivity and may support downside temporarily, but it does not establish a recurring earnings engine; elevated implied volatility makes outright common-stock exposure unattractive without a defined catalyst.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.38

Ticker Sentiment

BB0.48
CASY0.72
CRDO0.28
GME0.56

Key Decisions for Investors

  • CASY: maintain or initiate a 1-3 month long only on post-earnings consolidation; target a 8-12% move on upward EPS revisions, with a stop if next reported inside-sales gross margin or same-store sales decelerates materially versus management's prior trend. Do not chase a media-driven gap.
  • CRDO: build a small 6-12 month long versus short COHR or a semiconductor-equipment proxy only after confirming customer qualification/order commentary; target 20-30% upside if 224G design-win visibility emerges, with thesis invalidated by weaker hyperscaler demand or no revenue timing disclosure by the next two earnings reports.
  • GME: avoid directional long equity despite insider-flow support. For tactical exposure, monitor whether 30-day implied volatility spikes without a corporate catalyst; a defined-risk put spread 3-6 months out is preferable to short stock if price rises materially on retail flows while operating guidance remains unchanged.
  • BB: treat as a watch item rather than a position. Upgrade only if QNX discloses commercial contract value, production-program scale, or a credible path to segment-level operating leverage; otherwise, partnership headlines are insufficient to offset execution and valuation risk.

More News

From AllMind Research

Browse all research